Sanofi-Synthelabo

Laval, Canada

1

Total Recalls

0

Class I Recalls

0

Ongoing Recalls

Recalls by Sanofi-Synthelabo

FDA Drug Class II Terminated

Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manufactured by: Fabrique par Sanofi-Aventis Canada Inc., Laval, Quebec, Canada H7L4A8, DIN # 02091887

February 26, 2013 Sanofi-Synthelabo 998 Bottles units